Navigation Links
MU researcher calls for increase in sexual assault awareness programs on college campuses
Date:12/2/2008

ants blamed the victim when sexual assault occurred. Additionally, the majority of participants who were victims of previous sexual assault reported that they would make risky choices, including accepting a male acquaintance's offer to help them into their bedroom.

"The findings suggest that many incidents of drugging may be unreported or unsuspected," said Crawford, postdoctoral resident in behavioral health at the Harry S. Truman Memorial Veterans Hospital. "College students are likely to associate symptoms of nausea, blurred vision and lack of coordination with drinking too much alcohol, rather than suspect that another drug was unknowingly consumed."

At MU, several programs educate students about the dangers of date-rape drugs and sexual assault. The Relationship and Sexual Violence Prevention (RSVP) Center is a comprehensive relationship and sexual-violence education service. The resource center, in collaboration with the MU Women's Center, is driven by the work of four dedicated student organizations: the RSVP Peer Educators, the Greek Advocates, STARS (Stronger Together Against Relationship and Sexual Violence), and MARS (Men Against Relationship & Sexual Violence).

The RSVP Center offers outreach programs for residence halls, fraternities and sororities, classes and community organizations about topics, including rape and sexual violence. RSVP Peer Educators receive training on sexual assault, rape, intimate partner violence, and stalking. They use these skills to educate their peers through programs about issues related to relationship and sexual violence.

"We understand the need for all people to be aware of the potential of drug-facilitated rape and that college-aged women are a vulnerable population," said Sharon Giles, Coordinator of the Relationship and Sexual Violence Prevention Center at MU. "The RSVP center educates MU students about prevention by implementing systemic or community-wide change in creating a c
'/>"/>

Contact: Emily Smith
SmithEA@missouri.edu
573-882-3346
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. VisEn Co-Founder Named Radiologic Societys Outstanding Researcher of the Year
2. Children Tell Researchers: Well Get Fit if Its Fun
3. Researchers identify how binge drinking may drive heart disease
4. UCSD researchers identify potential new drug target for chronic leukemia
5. USC researchers identify novel approach for suppressing prostate cancer development
6. Researchers identify new leprosy bacterium
7. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs
8. Researchers discover strategy for predicting the immunity of vaccines
9. Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find
10. Researchers ID Suite of Genes in Aging Process
11. Rutgers researchers study cites media violence as critical risk factor for aggression
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 1Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 2Smoking Causes Blindness 61525 1Smoking Causes Blindness 61525 2Lampooning of U S Healthcare is Just What the Doctors Ordered as RoboDoc Begins its DVD Rounds on November 24th 21 61523 1Lampooning of U S Healthcare is Just What the Doctors Ordered as RoboDoc Begins its DVD Rounds on November 24th 21 61523 2